Citation Tools

Download PDFPDF

285 Phase I clinical trial evaluating the safety of ADP-A2M10 in patients with MAGE-A10+ head and neck, melanoma, or urothelial tumors

Download to a citation manager

Cite this article as:
Hong D, Butler M, Pachynski R, et al
285 Phase I clinical trial evaluating the safety of ADP-A2M10 in patients with MAGE-A10+ head and neck, melanoma, or urothelial tumors